Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Peroxisome proliferator–activated receptor alpha (PPARα) is a ligand-activated nuclear transcription factor and a member of the PPAR subfamily within the nuclear hormone receptor superfamily. It plays a master regulatory role in lipid metabolism, glucose homeostasis, inflammation, and vascular biology. Upon activation by endogenous ligands like free fatty acids or synthetic agonists like fibrates, PPARα forms heterodimers with RXR, binds to PPREs in DNA, and regulates the transcription of target genes involved in fatty acid uptake, utilization, and catabolism. It is a key therapeutic target for dyslipidemia and related metabolic disorders.
Fibrates bind to PPARα, promoting heterodimerization with RXR, binding to PPREs, and modulating gene transcription involved in lipid metabolism and inflammation.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Peroxisome proliferator–activated receptor alpha (PPARα).